Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Clinical trial NCT00886691 · COMPLETED

Trial details

NCT number: NCT00886691
Sponsor: GOG Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2010-12-27
Primary completion: 2014-06-27
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.